StockData
First Tracks Biotherapeutics, Inc. logo

First Tracks Biotherapeutics, Inc. (TRAX) stock

TRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026
$44.50+0.93 (+2.13%)

Close on Nov 18, 2026Market cap $1.59BP/E –Yield –

First Tracks Biotherapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for First Tracks Biotherapeutics

First Tracks Biotherapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More First Tracks Biotherapeutics figures

See a number that looks wrong?